Noubar Afeyan, Bob Langer, Tim Springer, and a host of other Boston biotech luminaries have been sitting on a big secret. Today we’re going to out them. | Continue reading
Xcelerating Life Sciences Fireside Chat Teresa Lavoie, principal at Fish & Richardson, speaks with Xconomy Managing Editor Dan Stanton about the legal complications of using machine learning and AI in discovering small molecule and biologic drugs, and how the patent landscape i … | Continue reading
Less than a year after reeling in a $83 million investment round, privately held microbiome startup uBiome has filed for bankruptcy and says its founders | Continue reading
Recorded Future is being acquired by tech investor Insight Partners in a $780 million all-cash deal, the cyber-threat intelligence company announced this | Continue reading
When we last covered the Linux Foundation’s Automotive Grade Linux (AGL) project---a collaborative, cross-industry, nonprofit effort to develop a common, | Continue reading
In June, Jennifer Petter, the founder and chief scientific officer of biotech startup Arrakis Therapeutics, got an e-mail from a stranger. His name was | Continue reading
With the first quarter in the books, it's time to step back and lay out Xconomy's editorial map for the rest of the year. As readers know, we strive to cov | Continue reading
The Thai chicken bowl from Spyce Food’s new restaurant in downtown Boston wasn’t life-changing, but it’s one of the better meals I’ve had from a “fast casu | Continue reading
California employers who classify their workers as independent contractors will be consulting their lawyers today, says A. Mark Pope, an attorney who helpe | Continue reading